Marinol, a registered trademark of Unimed Pharmaceuticals, Inc. is the commercial name for a product containing dronabinol, which is synthetic Δ9- THC.
Δ9-THC is a naturally occurring component of Marijuana.
Marinol is the only FDA-approved cannabinoid and is prescribed as an appetite stimulant, primarily for AIDS patients.